---
figid: PMC3049553__6606030f1
figtitle: MAPK pathway activation in melanoma
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC3049553
filename: 6606030f1.jpg
figlink: /pmc/articles/PMC3049553/figure/fig1/
number: F1
caption: The MAPK pathway activation in melanoma. Oncogenic NRAS, BRAF, GNAQ and CKIT
  signal through the MAPK pathway. Oncogenic NRAS also induces the phosphatidylinositol-3′
  kinase (PI3K) cascade. MAPK signalling can lead to proliferation in transformed
  cells, but also induces a potent form of growth arrest, known as senescence in normal
  melanocytes. The approximate proportion of melanomas with mutations are shown. GPCR=G-protein
  coupled receptor.
papertitle: Targeting BRAF for patients with melanoma.
reftext: H-T Arkenau, et al. Br J Cancer. 2011 Feb 1;104(3):392-398.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9546956
figid_alias: PMC3049553__F1
figtype: Figure
redirect_from: /figures/PMC3049553__F1
ndex: 063c8de3-deb5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3049553__6606030f1.html
  '@type': Dataset
  description: The MAPK pathway activation in melanoma. Oncogenic NRAS, BRAF, GNAQ
    and CKIT signal through the MAPK pathway. Oncogenic NRAS also induces the phosphatidylinositol-3′
    kinase (PI3K) cascade. MAPK signalling can lead to proliferation in transformed
    cells, but also induces a potent form of growth arrest, known as senescence in
    normal melanocytes. The approximate proportion of melanomas with mutations are
    shown. GPCR=G-protein coupled receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gpbar1
  - Kit
  - Nras
  - ras
  - Hras
  - Kras
  - Rem1
  - Gnaq
  - Zhx2
  - Braf
  - Braf-rs1
  - Grb2
  - Src
  - Map2k1
  - Map2k2
  - Pten
  - Pik3r1
  - Mapk3
  - Mapk1
  - Akt1
  - Cdkn2a
  - Trp53
  - Mtor
  - Pgr
  - Rb1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - KIT
  - NRAS
  - KRAS
  - HRAS
  - GNAQ
  - GNG10
  - GNG11
  - GNG12
  - GNG13
  - GNG2
  - GNG3
  - GNG4
  - GNG5
  - GNG7
  - GNG8
  - GNGT1
  - GNGT2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP2K1
  - MAP2K2
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPK3
  - MAPK1
  - AKT1
  - AKT2
  - AKT3
  - CDKN2A
  - TP53
  - TP63
  - TP73
  - MTOR
  - RB1
  - Oamb
  - blo
  - Ras64B
  - Ras85D
  - gg
  - Ggamma1
  - Ggamma30A
  - Raf
  - drk
  - Sos
  - Src42A
  - Csk
  - Src64B
  - Dsor1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - mid
  - rl
  - Akt
  - p53
  - betaTub60D
  - hth
  - Tor
  - Rbf
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Tyr
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
---
